Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F3QDT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,702
Award facts
- Contract value 100% obligated
- $19,702.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, valued at $19,702.03, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, awarded on December 1, 2025, represents a non-competitive set-aside procurement under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. Enbrel is a TNF inhibitor biologic used to treat rheumatoid arthritis, psoriasis, and other autoimmune conditions, indicating this delivery order supports federal medical supply needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a critical vendor in the federal pharmaceutical supply chain, AmerisourceBergen serves multiple government healthcare customers including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's established capability to fulfill specialized medical procurement requirements through established competitive processes.
Quick answers
Who was awarded contract SPE2DR26F3QDT?
SPE2DR26F3QDT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F3QDT worth?
The government has obligated $19,702 on SPE2DR26F3QDT.
Is contract SPE2DR26F3QDT an order under another contract?
Yes. SPE2DR26F3QDT is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QDT competed?
The extent of competition for SPE2DR26F3QDT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award